Global Biologics Contract Manufacturings Market Size, Status and Forecast 2022

Published On: Sep 2017

Format: PDF

Publisher: QY Research

Pages: 107

Report ID: 118590


This report studies the global Biologics Contract Manufacturings market, analyzes and researches the Biologics Contract Manufacturings development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Boehringer Ingelheim
Lonza
FUJIFILM Diosynth Biotechnologies USA
Rentschler Biotechnologie GmbH
Celonic AG
AutekBio Co Ltd
WuXiAppTec
Kemwell Biopharma
Shasun Pharma
Intas Pharmaceuticals
Syngene
Piramal Pharma Solutions
AAIPharma Services
Alpax Pharmaceuticals
Cantab Biopharmaceuticals Ltd
3P Biopharmaceuticals
BIBITEC GmbH

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Biologics Contract Manufacturings can be split into
Antisense
Cell Therapy
Gene Therapy
Growth Factors
Interferon's
Monoclonal Antibodies
Recombinant Hormones
RNA Interferences
Vaccines
Other

Market segment by Application, Biologics Contract Manufacturings can be split into
Hospitals
Clinics
Other


Table of Contents

Global Biologics Contract Manufacturings Market Size, Status and Forecast 2022
1 Industry Overview of Biologics Contract Manufacturings
1.1 Biologics Contract Manufacturings Market Overview
1.1.1 Biologics Contract Manufacturings Product Scope
1.1.2 Market Status and Outlook
1.2 Global Biologics Contract Manufacturings Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Biologics Contract Manufacturings Market by Type
1.3.1 Antisense
1.3.2 Cell Therapy
1.3.3 Gene Therapy
1.3.4 Growth Factors
1.3.5 Interferon's
1.3.6 Monoclonal Antibodies
1.3.7 Recombinant Hormones
1.3.8 RNA Interferences
1.3.9 Vaccines
1.3.10 Other
1.4 Biologics Contract Manufacturings Market by End Users/Application
1.4.1 Hospitals
1.4.2 Clinics
1.4.3 Other

2 Global Biologics Contract Manufacturings Competition Analysis by Players
2.1 Biologics Contract Manufacturings Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Boehringer Ingelheim
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Biologics Contract Manufacturings Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Lonza
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Biologics Contract Manufacturings Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 FUJIFILM Diosynth Biotechnologies USA
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Biologics Contract Manufacturings Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Rentschler Biotechnologie GmbH
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Biologics Contract Manufacturings Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Celonic AG
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Biologics Contract Manufacturings Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 AutekBio Co Ltd
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Biologics Contract Manufacturings Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 WuXiAppTec
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Biologics Contract Manufacturings Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Kemwell Biopharma
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Biologics Contract Manufacturings Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Shasun Pharma
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Biologics Contract Manufacturings Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Intas Pharmaceuticals
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Biologics Contract Manufacturings Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Syngene
3.12 Piramal Pharma Solutions
3.13 AAIPharma Services
3.14 Alpax Pharmaceuticals
3.15 Cantab Biopharmaceuticals Ltd
3.16 3P Biopharmaceuticals
3.17 BIBITEC GmbH

4 Global Biologics Contract Manufacturings Market Size by Type and Application (2012-2017)
4.1 Global Biologics Contract Manufacturings Market Size by Type (2012-2017)
4.2 Global Biologics Contract Manufacturings Market Size by Application (2012-2017)
4.3 Potential Application of Biologics Contract Manufacturings in Future
4.4 Top Consumer/End Users of Biologics Contract Manufacturings

5 United States Biologics Contract Manufacturings Development Status and Outlook
5.1 United States Biologics Contract Manufacturings Market Size (2012-2017)
5.2 United States Biologics Contract Manufacturings Market Size and Market Share by Players (2016 and 2017)

6 EU Biologics Contract Manufacturings Development Status and Outlook
6.1 EU Biologics Contract Manufacturings Market Size (2012-2017)
6.2 EU Biologics Contract Manufacturings Market Size and Market Share by Players (2016 and 2017)

7 Japan Biologics Contract Manufacturings Development Status and Outlook
7.1 Japan Biologics Contract Manufacturings Market Size (2012-2017)
7.2 Japan Biologics Contract Manufacturings Market Size and Market Share by Players (2016 and 2017)

8 China Biologics Contract Manufacturings Development Status and Outlook
8.1 China Biologics Contract Manufacturings Market Size (2012-2017)
8.2 China Biologics Contract Manufacturings Market Size and Market Share by Players (2016 and 2017)

9 India Biologics Contract Manufacturings Development Status and Outlook
9.1 India Biologics Contract Manufacturings Market Size (2012-2017)
9.2 India Biologics Contract Manufacturings Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Biologics Contract Manufacturings Development Status and Outlook
10.1 Southeast Asia Biologics Contract Manufacturings Market Size (2012-2017)
10.2 Southeast Asia Biologics Contract Manufacturings Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Biologics Contract Manufacturings Market Size (Value) by Regions (2017-2022)
11.1.1 United States Biologics Contract Manufacturings Revenue and Growth Rate (2017-2022)
11.1.2 EU Biologics Contract Manufacturings Revenue and Growth Rate (2017-2022)
11.1.3 Japan Biologics Contract Manufacturings Revenue and Growth Rate (2017-2022)
11.1.4 China Biologics Contract Manufacturings Revenue and Growth Rate (2017-2022)
11.1.5 India Biologics Contract Manufacturings Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Biologics Contract Manufacturings Revenue and Growth Rate (2017-2022)
11.2 Global Biologics Contract Manufacturings Market Size (Value) by Type (2017-2022)
11.3 Global Biologics Contract Manufacturings Market Size by Application (2017-2022)

12 Biologics Contract Manufacturings Market Dynamics
12.1 Biologics Contract Manufacturings Market Opportunities
12.2 Biologics Contract Manufacturings Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Biologics Contract Manufacturings Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Biologics Contract Manufacturings Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source